Impact of IFNL4 Genetic Variants on Sustained Virologic Response and Viremia in Hepatitis C Virus Genotype 3 Patients-Reference-Cited by-同舟云学术

Impact of IFNL4 Genetic Variants on Sustained Virologic Response and Viremia in Hepatitis C Virus Genotype 3 Patients

Published:2019-10-01 Issue:10 Volume:39 Page:642-649
ISSN:1079-9907
Container-title:Journal of Interferon & Cytokine Research
language:en
Short-container-title:Journal of Interferon & Cytokine Research

Author:

Pedergnana Vincent¹²,Irving William L.³,Barnes Eleanor⁴,McLauchlan John⁵,Spencer Chris C.A.¹,

Affiliation:

1. Wellcome Centre Human Genetics, University of Oxford, Oxford, United Kingdom.

2. Laboratoire MIVEGEC (UMR CNRS 5290, UR IRD 224, UM), Montpellier, France.

3. National Institute for Health Research (NIHR) Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and University of Nottingham, Nottingham, United Kingdom.

4. Nuffield Department of Medicine and the Oxford NIHR BRC, University of Oxford, Oxford, United Kingdom.

5. Centre for Virus Research, MRC-University of Glasgow, Glasgow, United Kingdom.

Publisher

Mary Ann Liebert Inc

Subject

Virology,Cell Biology,Immunology

Link

https://www.liebertpub.com/doi/pdf/10.1089/jir.2019.0013

Reference29 articles.

1. Fast Principal Component Analysis of Large-Scale Genome-Wide Data

2. Genome-to-genome analysis highlights the effect of the human innate and adaptive immune systems on the hepatitis C virus

3. Association of serum IFN-λ3 with inflammatory and fibrosis markers in patients with chronic hepatitis C virus infection

4. Impact of IFNL4 -∆G genotype on sustained virologic response in hepatitis C genotype 1 patients treated with direct-acting antivirals

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reduced IFNL1 and/or IFNL2, but not IFNL3 is associated with worse outcome in patients with COVID-19;Clinical and Experimental Immunology;2024-07-02

2. Variants of IFNL4 Gene in Amazonian and Northern Brazilian Populations;Genes;2023-11-14

3. Genetic Susceptibility to Hepatocellular Carcinoma in Patients with Chronic Hepatitis Virus Infection;Viruses;2023-02-17

4. Patient‐specific genetic factors predict treatment failure in sofosbuvir‐treated patients with chronic hepatitis C;Liver International;2022-02-21

5. WITHDRAWN: Analysis of host genetic variations associated with response to anti-HCV therapies in global populations;Meta Gene;2021-03